Johnson & Johnson has wasted no time expanding its portfolio. In the past two years it has invested more than $60 billion into research and development (R&D), as well as mergers and acquisitions, ...
Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $166 from $162 and keeps a Neutral rating on the ...
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
The With the First Pick RV is back in the garage after making stops at the Shrine and Senior Bowls the last two weeks. It's ...
John Force Racing has unveiled Austin Prock's 2025 livery featuring major sponsorships from Cornwell Tools and ...
Jim Knowles' defense is not static and is certainly malleable to suggestions, but even a veteran coach has a breaking point ...
A man is dead after an apparent shooting in Richmond on Sunday morning, according to city police. Officers responded at ...